The role of HER2 in angiogenesis☆
References (46)
- et al.
Signal transduction by receptors with tyrosine kinase activity
Cell
(1990) - et al.
The biology of the erbB-2/neu/HER2 and its role in cancer
Biochim Biophys Acta
(1994) - et al.
Patterns and emerging mechanism of the angiogenic switch during tumorigenesis
Cell
(1996) - et al.
The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
FEBS Lett
(1997) - et al.
Isolation of neu/HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells
Cell
(1992) - et al.
A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling
Cell
(1994) - et al.
Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase
J Biol Chem
(1998) - et al.
Secondary dimerization between members of the epidermal growth factor receptor family
J Biol Chem
(1997) - et al.
Epidermal growth factor related peptides and their receptors in human malignancies
Crit Rev Oncol Hematol
(1995) - et al.
Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3
J Biol Chem
(1995)
Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
Curr Opin Cell Biol
(1999)
Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: Preoperative determination of malignant potential
Eur J Surg Oncol
(1998)
Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-1-mediated angiogenesis
J Biol Chem
(2000)
Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis
Neuron
(1997)
Modulation of the organ microenvironment for treatment of cancer metastasis
J Natl Cancer Inst
(1995)
Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
Nat Med
(1995)
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
Am J Pathol
(1995)
Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
Cancer Res
(1995)
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Nature
(1992)
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors
Am J Pathol
(1997)
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
EMBO J
(1997)
Diversification of neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions
EMBO J
(1996)
Cited by (173)
miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review
2024, Biochemistry and Biophysics ReportsPrediction of Receptor Status in Radiomics: Recent Advances in Breast Cancer Research
2024, Academic RadiologyCombined expression of HIF1α, VEGF and HER2 predicts metastasis, relapse and response to combination chemotherapy in colorectal cancer patients
2023, Annals of Diagnostic PathologyOptimizing combination therapy in a murine model of HER2+ breast cancer
2022, Computer Methods in Applied Mechanics and Engineering
- ☆
Supported by the National Institutes of Health grants CA65746 and CA80066 and the Breast and Ovarian Research Programs of The University of Texas M. D. Anderson Cancer Center (RK).
Copyright © 2001 Published by Elsevier Inc.